BMI View: The challenges facing domestic pharmaceutical firms in Indonesia will continue. While efforts
to alleviate the country’s reliance on pharmaceutical raw material imports are underway, these are unlikely
to have a substantial impact until 2017. Moreover, the ability of Indonesia’s universal healthcare programme
to facilitate sales will be constrained by the country’s medical services infrastructure, and low commodity
prices will weigh on the economy and household purchasing power.
Headline Expenditure Projections
? Pharmaceuticals: IDR77,643bn (USD5.7bn) in 2015 to IDR85,550bn(USD5.9bn) in 2016; +10.2%
growth in local currency terms and 3.2% in US dollar terms.
? Healthcare: IDR347,253bn (USD25bn) in 2015 to IDR387,513bn (USD27bn) in 2016; +11.6% growth
in local currency terms and 4.6% in US dollar terms.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Indonesia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Indonesia 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2012-2020) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2012-2020) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2012-2020) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020) 24
Generic Drug Market Forecast 25
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020) 27
OTC Medicine Market Forecast 28
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020) 30
Pharmaceutical Trade Forecast 31
Table: Pharmaceutical Trade Data And Forecasts (Indonesia 2014-2020) 33
Table: Pharmaceutical Trade Data And Forecasts local currency (Indonesia 2014-2020) . 33
Industry Risk/Reward Index 34
Asia Pacific Risk/Reward Index 34
Indonesia Risk/Reward Index 40
Rewards 40
Risks 40
Regulatory Review 42
Pharmaceutical Advertising 44
Regional Harmonisation 45
Intellectual Property Issues 46
Halal Medicine Regulations 47
Labelling Requirements 48
Compulsory Licensing 48
Counterfeit Drugs 49
Generic Drug Legislation 50
Pricing Regime 51
Reimbursement Regime 52
Industry Trends And Developments 53
Market Overview 53
Public Health Developments 54
Table: UN Millennium Development Goals For Indonesia 54
Healthcare System 55
Health Insurance 56
Table: Healthcare Resources (Indonesia 2010-2015) 58
Table: Healthcare Personnel (Indonesia 2010-2015) 59
Table: Healthcare Activity (Indonesia 2010-2015) 59
Research & Development 59
Clinical Trials 60
Epidemiology 62
Table: Estimated Number Of New Cases Of Cancer In Indonesia 64
Competitive Landscape 67
Research-Based Industry 67
Table: Selected List Of Pharmaceutical Business Areas With Restricted Conditions 68
Table: Multinational Market Activity 69
Generic Drugmakers 70
Pharmaceutical Wholesale 71
Pharmaceutical Retail 72
Company Profile 75
Bayer 75
Darya-Varia Group 78
GlaxoSmithKline 81
Indopharma 84
Kimia Farma 87
Merck & Co 92
Merck Group 95
Novartis 99
Pfizer 102
PT Biofarma 105
PT Kalbe Farma 109
Sanofi 114
Soho Group 117
Demographic Forecast 120
Demographic Outlook 120
Table: Population Headline Indicators (Indonesia 1990-2025) 121
Table: Key Population Ratios (Indonesia 1990-2025) 121
Table: Urban/Rural Population & Life Expectancy (Indonesia 1990-2025) 122
Table: Population By Age Group (Indonesia 1990-2025) 122
Table: Population By Age Group % (Indonesia 1990-2025) 123
Glossary 125
Methodology 127
Pharmaceutical Expenditure Forecast Model 127
Healthcare Expenditure Forecast Model 127
Notes On Methodology 128
Risk/Reward Index Methodology 129
Index Overview 130
Table: Pharmaceutical Risk/Reward Index Indicators 130
Indicator Weightings 131

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Indonesia 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Indonesia 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Indonesia 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Indonesia 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Indonesia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Indonesia 2014-2020)
Table: UN Millennium Development Goals For Indonesia
Table: Healthcare Resources (Indonesia 2010-2015)
Table: Healthcare Personnel (Indonesia 2010-2015)
Table: Healthcare Activity (Indonesia 2010-2015)
Table: Estimated Number Of New Cases Of Cancer In Indonesia
Table: Selected List Of Pharmaceutical Business Areas With Restricted Conditions
Table: Multinational Market Activity
Table: Population Headline Indicators (Indonesia 1990-2025)
Table: Key Population Ratios (Indonesia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Indonesia 1990-2025)
Table: Population By Age Group (Indonesia 1990-2025)
Table: Population By Age Group % (Indonesia 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators